Detail
LncRNA Name | GRP78 |
Synonyms | NA |
Region | GRCh38_9:125234853-125241330 Sequence |
Ensembl | ENSG00000044574 |
RefSeq | NA |
Circulating | ✘ |
Drug-resisitant | ✔ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | prostate cancer |
ICD-0-3 | C61.9 |
Methods | qPCR etc. |
Sample | cell line (PC3PCA+ ) |
Expression Pattern | up-regulated |
Function Description | Three proteins were found down-regulated and 7 proteins up-regulated in PC3PCA+ cells compared to PC3NC cells,including GRP78.Higher GRP78 was also found in PCa clinical specimens.This study confirmed that in PCa, PCA3 plays a pro-cancer role through promoting cell proliferation, migration and invasion while inhibiting cell apoptosis. This process might involve the up-regulation of GRP78.GRP78 was also reported to be preferentially expressed in the camptothecin (CPT)- resistant PC3 prostate cancer cell line in comparison to the CPT-sensitive LNCaP prostate cancer cell line, which indicated its involvement in chemotherapy resistant in PCa. |
Pubmed ID | 28739722 |
Year | 2017 |
Title | GRP78 Participates in PCA3-regulated Prostate Cancer Progression. |
External Links |
Links for GRP78 | GenBank HGNC lncrnadb Noncode |
Links for prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.